It is reported that approximately 40 million people are suffering from dementia, globally.
Dementia is a group of symptoms that affect neurons and cause some mental disorders …

It is now well established that the blood-clotting protein fibrinogen can polymerise into an
anomalous form of fibrin that is amyloid in character; the resultant clots and microclots entrap …

Alzheimer's disease (AD) is a central neurodegenerative disorder characterized by
behavioral disturbance and progressive cognitive impairment, and it is common in pre …

Many researchers propose manipulating microbiota to prevent and treat related diseases.
The brain–gut axis is an object that remains the target of modern research, and it is not …

Since the first appearance of a novel coronavirus pneumonia (NCP) caused by a novel
human coronavirus, and especially after the infection started its rapid spread over the world …

The precise causation of Alzheimer's disease (AD) is unknown, and the factors that
contribute to its etiology are highly complicated. Numerous research has been conducted to …

Protein aggregation and subsequent accumulation of insoluble amyloid fibrils with cross-β
structure is an intrinsic characteristic of amyloid diseases, ie, amyloidoses. Amyloid …

Gut dysbiosis is observed in Alzheimer's disease (AD) and is frequently associated with AD-
induced metabolic dysfunction. However, the extent and specific underlying molecular …

Existing therapies for neurodegenerative diseases like Parkinson's and Alzheimer's address
only their symptoms and do not prevent disease onset. Common therapeutic agents, such as …

The liver partakes as a sensor and effector of peripheral metabolic changes and a regulator
of systemic blood and nutrient circulation. As such, abnormalities arising from liver …